Collplant生物技术 CLGN 深 沪
已收盘 07-02 16:00:00 美东时间
0.3402
0.000
-0.03%
华盛通- 最 高0.38
- 今 开0.38
- 成交量 1.28万股
- 最 低 0.3401
- 昨 收 0.3403
- 总市值 490.40万
- 52周最高 3.2324
- 市盈率 静 --
- 换手率 0.09%
- 52周最低 0.2711
- 委 比 -51.04%
- 总股本 1441.51万
- 历史最高 24.26
- 量 比 0.20
- 振 幅 11.72%
- 历史最低 0.2711
- 每 手 1
- 风险率 0.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CollPlant Biotechnologies Commences ~$2.6M Offering Of Ordinary Share, Warrants
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it has entered into a definitive agreement for the ...
06-30 20:13
10 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Gelteq (NASDAQ:GELS) shares moved upwards by 50.5% to $1.49 during Monday's pre-market session. The company's market cap stands at $10.6 million. Quantum Cyber (NASDAQ:QUCY) shares moved upwards by 15.58% to $2.0. The market value of their outstanding shares is at $39.3 million. Cypherpunk T...
06-15 20:05
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during F...
05-30 05:05
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy
From mining to biotech, these companies are exploring strategic alternatives, including a sale, to unlock growth and value.
05-30 02:15
CollPlant Biotechnologies shares are trading higher. The company reported Q1 financial results.
CollPlant Biotechnologies shares are trading higher. The company reported Q1 fi...
05-29 21:19
CollPlant Biotechnologies Q1 Adj. EPS $(0.21) Misses $(0.19) Estimate, Sales $73.000K Miss $1.100M Estimate
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 110 percent decrease over losses of $(0.10) per
05-29 19:07
CollPlant Biotechnologies shares are trading lower after the company announced the termination of its development agreement with AbbVie.
CollPlant Biotechnologies shares are trading lower after the company announced ...
04-13 22:44
CollPlant Issues Letter to Shareholders
REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprieta...
04-13 19:00
CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate.
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by 31.58 percent. This is a 16.67 percent increase over losses of $(0.30) per
03-26 20:34
